Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: Genetic prediction of antihyperglycemic drug targets and risk of epilepsy: a mendelian randomisation study

Fig. 5

Mendelian randomisation assessment of the ETFDH expression in brain_cortex and epilepsy risk in FinnGen. (see the legend on the previous Figure). (A) Mendelian randomisation effect size for ETFDH on finn-b-G6 epilepsy. (B) Mendelian randomisation leave-one-out sensitivity analysis for ETFDH on finn-b-G6 epilepsy. (C) EFTDH on finn-b-G6 epilepsy. (D) Single nucleotide polymorphism effect on ETFDH.

Back to article page